Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Common Equity: 2022-2025

Historic Common Equity for Prokidney (PROK) over the last 4 years, with Sep 2025 value amounting to -$1.0 billion.

  • Prokidney's Common Equity fell 2.89% to -$1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 billion, marking a year-over-year decrease of 2.89%. This contributed to the annual value of -$995.0 million for FY2024, which is 9.83% up from last year.
  • Per Prokidney's latest filing, its Common Equity stood at -$1.0 billion for Q3 2025, which was down 0.55% from -$1.0 billion recorded in Q2 2025.
  • In the past 5 years, Prokidney's Common Equity ranged from a high of -$12.4 million in Q1 2022 and a low of -$1.6 billion during Q1 2023.
  • For the 3-year period, Prokidney's Common Equity averaged around -$1.1 billion, with its median value being -$1.0 billion (2025).
  • Its Common Equity has fluctuated over the past 5 years, first plummeted by 12,856.87% in 2023, then soared by 31.56% in 2024.
  • Over the past 4 years, Prokidney's Common Equity (Quarterly) stood at -$1.1 billion in 2022, then declined by 0.62% to -$1.1 billion in 2023, then rose by 9.83% to -$995.0 million in 2024, then decreased by 2.89% to -$1.0 billion in 2025.
  • Its Common Equity was -$1.0 billion in Q3 2025, compared to -$1.0 billion in Q2 2025 and -$998.6 million in Q1 2025.